1. Barber TW, Duong CP, Leong T, Bressel M, Drummond EG, Hicks RJ. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. J Nucl Med. 2012;53:864–71.
2. Bruzzi JF, Munden RF, Truong MT, Marom EM, Sabloff BS, Gladish GW, Iyer RB, Pan TS, Macapinlac HA, Erasmus JJ. PET/CT of esophageal cancer: it’s role in clinical management. Radiographics. 2007;27(11):1635–52.
3. Gamboa EO, Cohen S, Ghesani M. The utility of PET/CT in monitoring treatment response and detecting unusual metastases in esophageal cancer. On-line HemOnc Today. 2009;10(12)
4. Heeren PAM, Jager PL, Bongaerts F, Van Dullemen H, Sluiter W, Plukker THM. Detection of distant metastases in esophageal cancer with 18F-FDG PET. J Nucl Med. 2004;45(6):980–7.
5. Hopkins S, Yang GY. Positron emission tomography’s utility in esophageal cancer management. J Thorac Dis. 2009;1:29–33.